questionsmedicales.fr
Actions chimiques et utilisations
Actions pharmacologiques
Utilisations thérapeutiques
Agents régulateurs de la reproduction
Contraceptifs
Contraceptifs féminins
Contraceptifs féminins : Questions médicales fréquentes
Diagnostic
5
Contraceptifs
Efficacité des contraceptifs
Tolérance aux médicaments
Antécédents médicaux
Effets secondaires
Consultation médicale
Grossesse
Symptômes de grossesse
Thrombose
Antécédents familiaux
Symptômes
5
Effets secondaires
Saignements
Réaction allergique
Eruptions cutanées
Douleurs abdominales
Contraceptifs
Grossesse
Symptômes de grossesse
Changements d'humeur
Dépression
Prévention
5
Prévention des grossesses
Méthodes contraceptives
Infections sexuellement transmissibles
Préservatifs
Éducation sexuelle
Options contraceptives
Contraception efficace
Consultation médicale
Traitements
5
Pilules contraceptives
Dispositifs intra-utérins
Choix de contraceptifs
Antécédents médicaux
Contraceptifs hormonaux
Sécurité des médicaments
Préservatifs
Utilisation correcte
Contraceptifs d'urgence
Efficacité
Complications
5
Risques des contraceptifs
Caillots sanguins
Gestion des complications
Consultation médicale
Cancer du sein
Contraceptifs
Thrombose
Signes d'alerte
Complications
Effets secondaires
Facteurs de risque
5
Facteurs de risque
Antécédents médicaux
Âge
Choix de contraceptifs
Antécédents médicaux
Thrombose
Obésité
Efficacité des contraceptifs
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Contraceptifs féminins : Questions médicales les plus fréquentes",
"headline": "Contraceptifs féminins : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Contraceptifs féminins : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-05",
"dateModified": "2026-06-23",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Contraceptifs féminins"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Contraceptifs",
"url": "https://questionsmedicales.fr/mesh/D003270",
"about": {
"@type": "MedicalCondition",
"name": "Contraceptifs",
"code": {
"@type": "MedicalCode",
"code": "D003270",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.954.705.360"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Contraceptifs oraux",
"alternateName": "Contraceptives, Oral",
"url": "https://questionsmedicales.fr/mesh/D003276",
"about": {
"@type": "MedicalCondition",
"name": "Contraceptifs oraux",
"code": {
"@type": "MedicalCode",
"code": "D003276",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.954.705.360.276.210"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Contraceptifs oraux combinés",
"alternateName": "Contraceptives, Oral, Combined",
"url": "https://questionsmedicales.fr/mesh/D003277",
"about": {
"@type": "MedicalCondition",
"name": "Contraceptifs oraux combinés",
"code": {
"@type": "MedicalCode",
"code": "D003277",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.954.705.360.276.210.100"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Contraceptifs oraux séquentiels",
"alternateName": "Contraceptives, Oral, Sequential",
"url": "https://questionsmedicales.fr/mesh/D003279",
"about": {
"@type": "MedicalCondition",
"name": "Contraceptifs oraux séquentiels",
"code": {
"@type": "MedicalCode",
"code": "D003279",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.954.705.360.276.210.400"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Contraceptifs oraux synthétiques",
"alternateName": "Contraceptives, Oral, Synthetic",
"url": "https://questionsmedicales.fr/mesh/D003280",
"about": {
"@type": "MedicalCondition",
"name": "Contraceptifs oraux synthétiques",
"code": {
"@type": "MedicalCode",
"code": "D003280",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.954.705.360.276.210.443"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Contraceptifs post-coïtaux",
"alternateName": "Contraceptives, Postcoital",
"url": "https://questionsmedicales.fr/mesh/D003281",
"about": {
"@type": "MedicalCondition",
"name": "Contraceptifs post-coïtaux",
"code": {
"@type": "MedicalCode",
"code": "D003281",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.954.705.360.276.310"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Contraceptifs post-coïtaux synthétiques",
"alternateName": "Contraceptives, Postcoital, Synthetic",
"url": "https://questionsmedicales.fr/mesh/D003283",
"about": {
"@type": "MedicalCondition",
"name": "Contraceptifs post-coïtaux synthétiques",
"code": {
"@type": "MedicalCode",
"code": "D003283",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.954.705.360.276.310.360"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Contraceptifs féminins",
"alternateName": "Contraceptive Agents, Female",
"code": {
"@type": "MedicalCode",
"code": "D003271",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Silvi Shah",
"url": "https://questionsmedicales.fr/author/Silvi%20Shah",
"affiliation": {
"@type": "Organization",
"name": "Division of Nephrology, Department of Internal Medicine, University of Cincinnati, Cincinnati, OH."
}
},
{
"@type": "Person",
"name": "Luis Bahamondes",
"url": "https://questionsmedicales.fr/author/Luis%20Bahamondes",
"affiliation": {
"@type": "Organization",
"name": "Department of Obstetrics and Gynecology, Faculty of Medical Sciences, University of Campinas (UNICAMP), Campinas, SP, Brazil."
}
},
{
"@type": "Person",
"name": "Clare Minahan",
"url": "https://questionsmedicales.fr/author/Clare%20Minahan",
"affiliation": {
"@type": "Organization",
"name": "Griffith Sports Physiology and Performance, School of Allied Health Sciences, Griffith University, Gold Coast, QLD, Australia."
}
},
{
"@type": "Person",
"name": "Jon E Hawkinson",
"url": "https://questionsmedicales.fr/author/Jon%20E%20Hawkinson",
"affiliation": {
"@type": "Organization",
"name": "University of Minnesota, Department of Obstetrics & Gynecology, Minneapolis, MN, USA."
}
},
{
"@type": "Person",
"name": "Ernst Schönbrunn",
"url": "https://questionsmedicales.fr/author/Ernst%20Sch%C3%B6nbrunn",
"affiliation": {
"@type": "Organization",
"name": "Moffitt Cancer Center, Drug Discovery Department, Tampa, FL, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Continuation rates of hormonal intrauterine devices in adolescents and young adults when placed for contraceptive and non-contraceptive indications.",
"datePublished": "2023-10-06",
"url": "https://questionsmedicales.fr/article/37806471",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.contraception.2023.110304"
}
},
{
"@type": "ScholarlyArticle",
"name": "Five-year Contraceptive Use of 52-mg Levonorgestrel Releasing Intrauterine System in Young Women, Menstrual Patterns, and New Contraceptive Choice.",
"datePublished": "2023-11-29",
"url": "https://questionsmedicales.fr/article/38029767",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1055/s-0043-1776032"
}
},
{
"@type": "ScholarlyArticle",
"name": "Risk of Stroke in Women Using Levonorgestrel-Releasing Intrauterine Device for Contraception.",
"datePublished": "2024-05-16",
"url": "https://questionsmedicales.fr/article/38753961",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1161/STROKEAHA.124.047438"
}
},
{
"@type": "ScholarlyArticle",
"name": "Nexplanonectomy-the surgical removal of an embolized implanted contraceptive device: a case report and review of the literature.",
"datePublished": "2024-05-02",
"url": "https://questionsmedicales.fr/article/38698425",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13256-024-04547-7"
}
},
{
"@type": "ScholarlyArticle",
"name": "Perceptions of access to long-acting reversible contraception removal among women in Burkina Faso.",
"datePublished": "2023-10-05",
"url": "https://questionsmedicales.fr/article/37802461",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.contraception.2023.110302"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Actions chimiques et utilisations",
"item": "https://questionsmedicales.fr/mesh/D020164"
},
{
"@type": "ListItem",
"position": 3,
"name": "Actions pharmacologiques",
"item": "https://questionsmedicales.fr/mesh/D020228"
},
{
"@type": "ListItem",
"position": 4,
"name": "Utilisations thérapeutiques",
"item": "https://questionsmedicales.fr/mesh/D045506"
},
{
"@type": "ListItem",
"position": 5,
"name": "Agents régulateurs de la reproduction",
"item": "https://questionsmedicales.fr/mesh/D012102"
},
{
"@type": "ListItem",
"position": 6,
"name": "Contraceptifs",
"item": "https://questionsmedicales.fr/mesh/D003270"
},
{
"@type": "ListItem",
"position": 7,
"name": "Contraceptifs féminins",
"item": "https://questionsmedicales.fr/mesh/D003271"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Contraceptifs féminins - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Contraceptifs féminins",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-09-04",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Contraceptifs féminins",
"description": "Comment savoir si un contraceptif est efficace ?\nQuels tests pour évaluer la tolérance aux contraceptifs ?\nQuand consulter un médecin pour des effets secondaires ?\nQuels signes indiquent une grossesse malgré la contraception ?\nComment évaluer le risque de thrombose avec un contraceptif ?",
"url": "https://questionsmedicales.fr/mesh/D003271#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Contraceptifs féminins",
"description": "Quels sont les effets secondaires courants des contraceptifs ?\nComment reconnaître une réaction allergique aux contraceptifs ?\nLes contraceptifs peuvent-ils causer des douleurs abdominales ?\nQuels symptômes indiquent une grossesse avec un contraceptif ?\nLes contraceptifs affectent-ils l'humeur ?",
"url": "https://questionsmedicales.fr/mesh/D003271#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Contraceptifs féminins",
"description": "Comment prévenir les grossesses non désirées ?\nLes contraceptifs protègent-ils des IST ?\nQuelle est l'importance de l'éducation sexuelle ?\nComment parler de contraception avec son partenaire ?\nQuels conseils pour une contraception efficace ?",
"url": "https://questionsmedicales.fr/mesh/D003271#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Contraceptifs féminins",
"description": "Quels types de contraceptifs féminins existent ?\nComment choisir un contraceptif adapté ?\nLes contraceptifs hormonaux sont-ils sûrs ?\nComment utiliser correctement un préservatif féminin ?\nLes contraceptifs d'urgence sont-ils efficaces ?",
"url": "https://questionsmedicales.fr/mesh/D003271#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Contraceptifs féminins",
"description": "Quels sont les risques associés aux contraceptifs ?\nComment gérer les complications liées aux contraceptifs ?\nLes contraceptifs peuvent-ils causer des cancers ?\nQuels signes d'alerte pour une thrombose ?\nLes complications sont-elles fréquentes avec les contraceptifs ?",
"url": "https://questionsmedicales.fr/mesh/D003271#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Contraceptifs féminins",
"description": "Quels facteurs augmentent le risque de complications ?\nComment le tabagisme affecte-t-il la contraception ?\nL'âge influence-t-il le choix des contraceptifs ?\nQuels antécédents médicaux sont préoccupants ?\nComment l'obésité affecte-t-elle la contraception ?",
"url": "https://questionsmedicales.fr/mesh/D003271#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment savoir si un contraceptif est efficace ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité est mesurée par le taux d'échec, qui varie selon la méthode choisie."
}
},
{
"@type": "Question",
"name": "Quels tests pour évaluer la tolérance aux contraceptifs ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des examens médicaux et des antécédents médicaux sont nécessaires pour évaluer la tolérance."
}
},
{
"@type": "Question",
"name": "Quand consulter un médecin pour des effets secondaires ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consultez un médecin si vous ressentez des effets secondaires graves ou persistants."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une grossesse malgré la contraception ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Retard de règles, nausées, fatigue ou changements d'appétit peuvent indiquer une grossesse."
}
},
{
"@type": "Question",
"name": "Comment évaluer le risque de thrombose avec un contraceptif ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évaluez les antécédents familiaux et personnels de thrombose avant de choisir un contraceptif."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires courants des contraceptifs ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires incluent des nausées, des maux de tête et des saignements irréguliers."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une réaction allergique aux contraceptifs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des démangeaisons, des éruptions cutanées ou un gonflement peuvent indiquer une allergie."
}
},
{
"@type": "Question",
"name": "Les contraceptifs peuvent-ils causer des douleurs abdominales ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines femmes peuvent ressentir des douleurs abdominales dues à des contraceptifs."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une grossesse avec un contraceptif ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Retard de règles, fatigue, et nausées peuvent indiquer une grossesse malgré la contraception."
}
},
{
"@type": "Question",
"name": "Les contraceptifs affectent-ils l'humeur ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines femmes rapportent des changements d'humeur, comme l'anxiété ou la dépression."
}
},
{
"@type": "Question",
"name": "Comment prévenir les grossesses non désirées ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utilisez des méthodes contraceptives fiables et consultez un professionnel de santé."
}
},
{
"@type": "Question",
"name": "Les contraceptifs protègent-ils des IST ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, seuls les préservatifs protègent contre les infections sexuellement transmissibles (IST)."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de l'éducation sexuelle ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'éducation sexuelle aide à comprendre les options contraceptives et à prendre des décisions éclairées."
}
},
{
"@type": "Question",
"name": "Comment parler de contraception avec son partenaire ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Soyez ouvert et honnête sur vos préférences et préoccupations concernant la contraception."
}
},
{
"@type": "Question",
"name": "Quels conseils pour une contraception efficace ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Suivez les instructions d'utilisation, consultez régulièrement un médecin et soyez cohérente."
}
},
{
"@type": "Question",
"name": "Quels types de contraceptifs féminins existent ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les types incluent les pilules, les dispositifs intra-utérins (DIU) et les implants."
}
},
{
"@type": "Question",
"name": "Comment choisir un contraceptif adapté ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le choix dépend des préférences personnelles, des antécédents médicaux et de l'efficacité."
}
},
{
"@type": "Question",
"name": "Les contraceptifs hormonaux sont-ils sûrs ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont généralement sûrs, mais peuvent ne pas convenir à toutes les femmes."
}
},
{
"@type": "Question",
"name": "Comment utiliser correctement un préservatif féminin ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Insérez-le avant tout rapport sexuel et assurez-vous qu'il est bien en place."
}
},
{
"@type": "Question",
"name": "Les contraceptifs d'urgence sont-ils efficaces ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont efficaces s'ils sont pris dans les 72 heures suivant un rapport non protégé."
}
},
{
"@type": "Question",
"name": "Quels sont les risques associés aux contraceptifs ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les risques incluent des caillots sanguins, des AVC et des effets secondaires graves."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications liées aux contraceptifs ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consultez un médecin immédiatement en cas de symptômes graves ou inhabituels."
}
},
{
"@type": "Question",
"name": "Les contraceptifs peuvent-ils causer des cancers ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent un lien entre certains contraceptifs et un risque accru de cancer du sein."
}
},
{
"@type": "Question",
"name": "Quels signes d'alerte pour une thrombose ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Douleurs dans les jambes, gonflement ou rougeur peuvent indiquer une thrombose."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles fréquentes avec les contraceptifs ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications graves sont rares, mais il est important de surveiller les effets secondaires."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de complications ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge, le tabagisme, l'obésité et les antécédents médicaux augmentent les risques."
}
},
{
"@type": "Question",
"name": "Comment le tabagisme affecte-t-il la contraception ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tabagisme augmente le risque de thrombose avec certains contraceptifs hormonaux."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le choix des contraceptifs ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les femmes plus âgées peuvent avoir besoin de méthodes spécifiques en raison de risques accrus."
}
},
{
"@type": "Question",
"name": "Quels antécédents médicaux sont préoccupants ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents de thrombose, AVC ou cancer peuvent influencer le choix des contraceptifs."
}
},
{
"@type": "Question",
"name": "Comment l'obésité affecte-t-elle la contraception ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'obésité peut réduire l'efficacité de certains contraceptifs et augmenter les risques de complications."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 23/06/2026
Contenu vérifié selon les dernières recommandations médicales
└─
Contraceptifs oraux
Contraceptives, Oral
D003276 -
D27.505.954.705.360.276.210
└─
Contraceptifs post-coïtaux
Contraceptives, Postcoital
D003281 -
D27.505.954.705.360.276.310
└─└─
Contraceptifs oraux combinés
Contraceptives, Oral, Combined
D003277 -
D27.505.954.705.360.276.210.100
└─└─
Contraceptifs oraux séquentiels
Contraceptives, Oral, Sequential
D003279 -
D27.505.954.705.360.276.210.400
└─└─
Contraceptifs oraux synthétiques
Contraceptives, Oral, Synthetic
D003280 -
D27.505.954.705.360.276.210.443
└─└─
Contraceptifs post-coïtaux synthétiques
Contraceptives, Postcoital, Synthetic
D003283 -
D27.505.954.705.360.276.310.360
2 publications dans cette catégorie
Affiliations :
Division of Nephrology, Department of Internal Medicine, University of Cincinnati, Cincinnati, OH.
Publications dans "Contraceptifs féminins" :
2 publications dans cette catégorie
Affiliations :
Department of Obstetrics and Gynecology, Faculty of Medical Sciences, University of Campinas (UNICAMP), Campinas, SP, Brazil.
Publications dans "Contraceptifs féminins" :
2 publications dans cette catégorie
Affiliations :
Griffith Sports Physiology and Performance, School of Allied Health Sciences, Griffith University, Gold Coast, QLD, Australia.
Publications dans "Contraceptifs féminins" :
2 publications dans cette catégorie
Affiliations :
University of Minnesota, Department of Obstetrics & Gynecology, Minneapolis, MN, USA.
Publications dans "Contraceptifs féminins" :
2 publications dans cette catégorie
Affiliations :
Moffitt Cancer Center, Drug Discovery Department, Tampa, FL, USA.
Publications dans "Contraceptifs féminins" :
2 publications dans cette catégorie
Affiliations :
University of Minnesota, Department of Obstetrics & Gynecology, Minneapolis, MN, USA.
Publications dans "Contraceptifs féminins" :
2 publications dans cette catégorie
Affiliations :
Canadian Sport Institute-Pacific, Victoria, British Columbia, Canada.
Exercise Science, Physical and Health Education, University of Victoria, Victoria, British Columbia, Canada.
Publications dans "Contraceptifs féminins" :
2 publications dans cette catégorie
Affiliations :
Department of Medical Microbiology, University of Nairobi, GPO, Nairobi, Kenya.
Publications dans "Contraceptifs féminins" :
1 publication dans cette catégorie
Affiliations :
Department of Obstetrics and Gynecology, Columbia University Irving Medical Center, New York, NY; Department of Obstetrics and Gynecology, University of Colorado Anschutz Medical Center, Aurora, CO. Electronic address: nancy.fang@cuanschutz.edu.
Publications dans "Contraceptifs féminins" :
1 publication dans cette catégorie
Affiliations :
Department of Epidemiology, Columbia University Mailman School of Public Health, New York, NY.
Publications dans "Contraceptifs féminins" :
1 publication dans cette catégorie
Affiliations :
Department of Obstetrics and Gynecology, Columbia University Irving Medical Center, New York, NY.
Publications dans "Contraceptifs féminins" :
1 publication dans cette catégorie
Affiliations :
Department of Obstetrics and Gynecology, Columbia University Irving Medical Center, New York, NY.
Publications dans "Contraceptifs féminins" :
1 publication dans cette catégorie
Affiliations :
Department of Obstetrics and Gynecology, Columbia University Irving Medical Center, New York, NY; Department of Epidemiology, Columbia University Mailman School of Public Health, New York, NY.
Publications dans "Contraceptifs féminins" :
1 publication dans cette catégorie
Affiliations :
Department of Gynecology and Obstetrics, Hospital Dr. Nélio Mendonça, Serviço de Saúde da Região Autónoma da Madeira, E.P.E., Funchal, Portugal.
Publications dans "Contraceptifs féminins" :
1 publication dans cette catégorie
Affiliations :
Department of Gynecology and Obstetrics, Hospital Dr. Nélio Mendonça, Serviço de Saúde da Região Autónoma da Madeira, E.P.E., Funchal, Portugal.
Publications dans "Contraceptifs féminins" :
1 publication dans cette catégorie
Affiliations :
Division of Neurology, Children's Hospital Los Angeles, Los Angeles, CA 90027, USA; Department of Neurology, Keck School of Medicine at the University of Southern California, Los Angeles, CA 90027, USA. Electronic address: jdsantoro@chla.usc.edu.
Publications dans "Contraceptifs féminins" :
1 publication dans cette catégorie
Affiliations :
Department of Neurology, Keck School of Medicine at the University of Southern California, Los Angeles, CA 90027, USA.
Publications dans "Contraceptifs féminins" :
1 publication dans cette catégorie
Affiliations :
Division of Neurology, Children's Hospital Los Angeles, Los Angeles, CA 90027, USA.
Publications dans "Contraceptifs féminins" :
1 publication dans cette catégorie
Affiliations :
Keck School of Medicine at the University of Southern California, Los Angeles, CA 90027, USA.
Publications dans "Contraceptifs féminins" :
1 publication dans cette catégorie
Affiliations :
Division of Neurology, Children's Hospital Los Angeles, Los Angeles, CA 90027, USA.
Publications dans "Contraceptifs féminins" :
This study aimed to estimate and compare continuation rates of hormonal intrauterine devices (IUDs) when placed for contraceptive or menstrual management indications in adolescents and young adults....
We conducted a secondary analysis of a prospectively collected database of all hormonal IUD insertions from January 1, 2017 through December 31, 2020, with at least 1-year follow-up, across four Adole...
A total of 936 IUD insertions were attempted, 45% for contraception only, 18% for menstrual management only, and 37% for both indications. Insertion was successful in 868 (93%) attempts, and success d...
IUD continuation rates were high among adolescents and young adults and did not significantly differ when placed for contraceptive or non-contraceptive indication in the first year of use....
Adolescents and young adults may seek the hormonal IUD for contraception and/or menstrual management. Our study found that IUD continuation rates were high at 1 year regardless of the indication for u...
To evaluate the continuation rates of the 52-mg levonorgestrel-releasing intrauterine system (LNG-IUS) during the first 5 years of use, reasons for its discontinuation, bleeding patterns, and new cont...
The present study was a 5-year prospective cohort conducted in a Family Planning Service of a tertiary hospital in Brazil. We selected 100 healthy women between 15 and 24 years old who used 52-mg LNG-...
The continuation rates of LNG-IUS were 89.1% (82/92), 82.9% (72/87), 75.3% (64/85), 70.5% (60/85), and 64.2% (54/84) in the 1...
The LNG-IUS showed high continuation rates in adolescents and young women in the first 5 years of use. Most patients who completed the study chose a LARC method after the 5...
The commonly used combined hormonal contraceptives with progestins and ethinylestradiol are associated with an increased risk of ischemic stroke (IS). Progestin-only preparations, including levonorges...
In this Danish historical cohort study (2004-2021), we followed nonpregnant women (18-49 years) registering incident IS and ICH in relation to use of LG-IUDs/nonuse of hormonal contraceptives utilizin...
A total of 1 681 611 nonpregnant women contributed 11 971 745 person-years (py) of observation. Mean age at inclusion was 30.0 years; mean length of follow-up was 7.1 years; 2916 women (24.4 per 100 0...
The use of LG-IUD was associated with a 22% lower incidence rate of IS without raising the incidence rate of ICH. The finding raises the question of whether levonorgestrel, in addition to its contrace...
Nexplanon implants are a common hormonal contraceptive modality. Though rare, these devices can embolize into the injured wall of the basilic vein, through the right heart, and finally wedge itself in...
A 22-year-old asymptomatic active-duty Caucasian female presented for elective outpatient Nexplanon removal. The suspicion of possible implant migration arose when it was discovered to be non-palpable...
Implanted contraceptive devices can rarely result in migration to the pulmonary vasculature. These radiopaque devices are detectable on imaging studies if patients and clinicians are unable to palpate...
Long-acting reversible contraception (LARC) initiation has been well-studied and intervened upon. Because LARC requires provider intervention for initiation and removal, it is critical to measure info...
We analyzed data from a 2017-2018 population-based, cross-sectional survey of 281 implant users and 55 intrauterine device users at two sites in Burkina Faso. We measured perceptions of access to LARC...
Thirty-eight (11%) of current LARC users reported that they were not informed on how to discontinue, 56 (17%) believed having their device removed would be difficult, and 54 (16%) believed cost would ...
Findings indicate that LARC uptake is an insufficient measure of reproductive access or choice. Future studies should include patient-centered measures that span the full duration of contraceptive use...
This paper finds that a sizable proportion of LARC users lack information about method discontinuation and perceive or experience barriers to method removal. These findings call for a reconsideration ...
Implant-site necrosis is a rare complication. We present a case-series of a necrosis as an adverse effect after the etonogestrel (ENG)-subdermal contraceptive implant placement....
Five women with site necrosis after the ENG-implant placement and their clinical manifestations and treatments....
Local pain was the main symptom, appearing within 35 days of placement. Outpatient multidisciplinary treatment was undertaken. Local debridement and implant removal was performed in four out of the fi...
Early diagnosis and multidisciplinary treatment are essential to avoid severe aesthetic or functional damages and major life-threatening complications....
Women in Kenya have an unmet need for contraception, and self-injectable contraceptives offer a new, self-managed fertility control option. Self-injection reduces the need to travel to a facility for ...
This study aimed to observe and document the design process of a WhatsApp delivered self-injectable contraceptive service. This design evaluation employs a mixed methods approach using; observation of...
Four tasks, delivered by the digital service, were explored in further detail: provide information on self-injectables; ensure the technical and privacy requirements of the video call are met; obtain ...
By examining self-care facilitated by digital technologies, there are opportunities to learn about self-care, digital care and face-to-face care. Through examining the design process, we discovered wa...
Adolescent girls bear a disproportionate burden of both the HIV epidemic and unintended pregnancies; yet important questions remain unanswered regarding the effects of hormonal contraceptives on the v...
To evaluate gene expression associated with unfavorable vaginal bleeding in users of the Etonogestrel (ENG) contraceptive implant. Prospective study involving 100 women who intended to use the ENG imp...
To evaluate if inter-individual variability in serum etonogestrel (ENG) concentrations accounts for variability in mood-related side effects among ENG implant users....
Participants underwent a single-time blood draw for measurement of serum ENG concentrations using a liquid-chromatography mass-spectrometry assay, and completed a questionnaire at enrollment that retr...
Among 900 enrolled participants, 34% (306/900) reported mood changes on the baseline questionnaire. Of these, 31 (3.4%) participants also had documented PHQ-9 scores. Serum ENG concentrations (median ...
Pharmacokinetic variability does not explain the inter-individual variability in mood-related side effects among ENG implant users....
Mood-related side effects and altered mental health metrics are commonly reported by etonogestrel contraceptive implant users but demonstrate wide inter-individual variability. Individual differences ...